BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

713 related articles for article (PubMed ID: 18163149)

  • 1. Endometrial carcinoma following treatment for breast carcinoma in a Nigerian female. A case report and review of the literature.
    Abudu EK; Musa O; Adefuye PO; Abdul Kareem FB; Agboola AO; Banjo AA
    Niger Postgrad Med J; 2007 Dec; 14(4):355-7. PubMed ID: 18163149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Risk of endometrial hyperplasia and carcinoma in breast cancer patients receiving adjuvant tamoxifen].
    Semiglazov VF; Maksimov SIa; Bulgatova EA; Meshkova IE; Chepik OF; Berstein LM
    Vopr Onkol; 2003; 49(2):198-204. PubMed ID: 12785205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endometrial cancer and recurrence with hormonal manipulation.
    Ghosh P; Fawzi H
    J Obstet Gynaecol; 2004 Feb; 24(2):192-3. PubMed ID: 14766474
    [No Abstract]   [Full Text] [Related]  

  • 4. Detection of endometrial cancer in asymptomatic postmenopausal breast cancer patient treated with tamoxifen: a case report.
    Sinawat S; Chiyabutra T; Kleabkaew P
    J Med Assoc Thai; 2001 Jul; 84(7):1033-6. PubMed ID: 11759963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [MR Imaging of the pelvis in the diagnosis of the endometrium in breast cancer patients in tamoxifen therapy].
    Hauth E; Libera H; Kimmig R; Forsting M
    Rofo; 2006 Mar; 178(3):316-23. PubMed ID: 16508840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-grade endometrial stromal sarcoma following tamoxifen treatment.
    Engin H
    Gynecol Oncol; 2008 Jan; 108(1):253-4. PubMed ID: 17928038
    [No Abstract]   [Full Text] [Related]  

  • 7. [Endometrial adenocarcinoma appearing during tamoxifen therapy. Report of a clinical case].
    Menada MV; Corticelli A; Giannesi A; Nicoletti L; Podesta M; Rissone R; Fulcheri E
    Minerva Ginecol; 2000 Dec; 52(12):521-6. PubMed ID: 11310150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iatrogenic endometrial megapolyps in women with breast carcinoma.
    Berezowsky J; Chalvardjian A; Murray D
    Obstet Gynecol; 1994 Oct; 84(4 Pt 2):727-30. PubMed ID: 9205466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tamoxifen and endometrial cancer. A case report].
    Orbo A; Lindal S; Mortensen E
    Tidsskr Nor Laegeforen; 1996 Jun; 116(16):1877-8. PubMed ID: 8711699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cancer of the endometrium caused by antiestrogens].
    Le Bouëdec G; Dauplat J
    Rev Fr Gynecol Obstet; 1992 Jun; 87(6):345-8. PubMed ID: 1631476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tamoxifen and malignant epithelial-nonepithelial tumours of the endometrium: report of six cases and review of the literature.
    Treilleux T; Mignotte H; Clement-Chassagne C; Guastalla P; Bailly C
    Eur J Surg Oncol; 1999 Oct; 25(5):477-82. PubMed ID: 10527595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A retrospective study of tamoxifen and endometrial cancer in breast cancer patients.
    Robinson DC; Bloss JD; Schiano MA
    Gynecol Oncol; 1995 Nov; 59(2):186-90. PubMed ID: 7590470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Adjuvant therapy of breast cancer with tamoxifen and endometrial carcinoma].
    Mignotte H; Sasco AJ; Lasset C; Saez S; Rivoire M; Bobin JY
    Bull Cancer; 1992; 79(10):969-77. PubMed ID: 1292764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The incidence of subsequent endometrial carcinoma with tamoxifen use in patients with primary breast carcinoma.
    Katase K; Sugiyama Y; Hasumi K; Yoshimoto M; Kasumi F
    Cancer; 1998 May; 82(9):1698-703. PubMed ID: 9576291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Endometrial cancer and tamoxifen. Discussion apropos of a series of cases].
    Sasco AJ; Ah-Song R; Gendre I; Zlatoff P; Bobin JY; Hallonet P; Leduc B
    Bull Cancer; 1997 Jan; 84(1):51-60. PubMed ID: 9180860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endometrial cancer in patients with breast carcinoma treated with tamoxifen: report of two cases and the literature overview.
    Sliwińska M; Wojtacki J; Sliwiński W
    Med Sci Monit; 2000; 6(2):399-406. PubMed ID: 11208346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tamoxifen mediated human endometrial carcinogenesis may not involve estrogenic pathways: a preliminary note.
    Kuwashima Y; Kurosumi M; Kobayashi Y; Tanuma J; Suemasu K; Higashi Y; Kasamatsu T; Shiromizu K; Matsuzawa M; Kishi K
    Anticancer Res; 1996; 16(5A):2993-6. PubMed ID: 8917418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tamoxifen, screening and new oestrogen receptor modulators.
    Neven P; Vergote I
    Best Pract Res Clin Obstet Gynaecol; 2001 Jun; 15(3):365-80. PubMed ID: 11476559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asymptomatic carcinoma of the endometrium in a patient on adjunctive tamoxifen therapy for carcinoma of the breast.
    O'Neill E; Rodríguez Mojica W
    Bol Asoc Med P R; 1992 Feb; 84(2):74-7. PubMed ID: 1388459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tamoxifen treatment for breast cancer and risk of endometrial cancer: a case-control study.
    Swerdlow AJ; Jones ME;
    J Natl Cancer Inst; 2005 Mar; 97(5):375-84. PubMed ID: 15741574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.